Mitochondrial dysfunction is considered to be an important mediator of the proaging process in chronic kidney disease, which is continuously increasing worldwide.Although PTEN-induced kinase 1 (PINK1) regulates mitochondrial function, its role in renal aging remains unclear. We investigated the association between PINK1 and
Most eukaryotic cells have mitochondrial networks that can change in shape, distribution, and size depending on cellular metabolic demands and environments. Mitochondrial quality control is critical for various mitochondrial functions including energy production, redox homeostasis, intracellular calcium handling, cell differentiation, proliferation, and cell death. Quality control mechanisms within mitochondria consist of antioxidant defenses, protein quality control, DNA damage repair systems, mitochondrial fusion and fission, mitophagy, and mitochondrial biogenesis. Defects in mitochondrial quality control and disruption of mitochondrial homeostasis are common characteristics of various kidney cell types under hyperglycemic conditions. Such defects contribute to diabetes-induced pathologies in renal tubular cells, podocytes, endothelial cells, and immune cells. In this review, we focus on the roles of mitochondrial quality control in diabetic kidney disease pathogenesis and discuss current research evidence and future directions.
Background and Aims The global increase of an aging population has encouraged the research on renal aging, as the kidney is one of the organs that shows the greatest change as aging progresses. Although the mechanism of renal aging has not been clearly identified, dysfunctional mitochondria has been suggested as one of the factors that induce inflammation of the kidney, which is the major mediator of the pro-aging process of chronic kidney disease. PTEN-induced kinase 1(PINK1) is a protein involved in the quality control of mitochondria and regulates mitochondrial dysfunction. Although it is known that the mitochondrial DNA release promoted by PINK1 deficiency stimulates cyclic GMP–AMP synthase (cGAS) - stimulator of interferon genes (STING) pathway eventually resulting in the inflammatory response, the role of PINK1 and cGAS-STING pathway in renal aging has not yet been clarified. This study aimed to investigate the relationship between PINK1 and renal aging, especially through the cGAS-STING pathway. Method To determine the role of PINK1 on the renal aging process, renal fibrosis, and tubular injury were compared in 4- and 24-month-old wild-type (Pink1+/+) and PINK1 knockout (Pink1-/-) mice. To establish in vitro senescence model, hydrogen peroxide (H2O2) treatment on human renal proximal cells (HKC-8) was used. The changes in gene expression levels related to PINK1 were analyzed by RNA sequencing, applying transcriptomic and metabolomic analyses. To validate the results of RNA sequencing, we measured mitochondrial oxygen consumption rate (OCR) by Seahorse Mito Stress Test. To investigate the relationship between PINK1 and renal aging through the cGAS-STING pathway, we explored the change of cGAS-STING expression on senescence-induced HKC-8 cells and additionally used H-151 treatment, a specific STING inhibitor. Results The renal fibrosis and tubular injury were significantly aggravated in 24-month-old Pink1-/- mice compared to 24-month-old Pink1+/+ mice. Western blot and RT-qPCR confirmed remarkably increased senescence markers and senescence-associated secretory phenotype (SASPs) in 24-month Pink1-/- mice and senescence-induced HKC-8 cells. The RNA sequencing of mice kidneys showed that inflammation-related pathways significantly increased in 24 months Pink1-/-mice, and transcriptomic and metabolomic analyses showed that PINK1 has an association with mitochondrial metabolism dysregulation. On OCR measurement, the basal respiration, maximal respiration, ATP production, and respiratory capacity significantly declined in H2O2-treated siPINK1 cells, suggesting that PINK1 deficiency might have effects on mitochondrial dysfunction. Finally, the STING pathway was significantly activated in 24-month Pink1-/- mice and senescence-induced HKC-8 cells, which was inhibited by a specific inhibitor of STING, H-151. Conclusion In conclusion, PINK1 is associated with renal aging, and the dysregulation of mitochondria caused by PINK1 deficiency might lead to aging-related inflammatory responses through the cGAS-STING pathway.
Background: Frailty is defined as a condition of being weak and delicate, and it represents a state of high vulnerability to adverse health outcomes. Recent studies have suggested that the cingulate gyrus is associated with frailty in the elderly population. However, few imaging studies have explored the relationship between frailty and the cingulate gyrus in patients with end-stage renal disease (ESRD) undergoing hemodialysis. Methods: Eighteen right-handed patients with ESRD undergoing hemodialysis were enrolled in the study. We used the FreeSurfer software package to estimate the cortical thickness of the regions of interest, including the rostral anterior, caudal anterior, isthmus, and posterior cingulate gyri. The Beck Depression Inventory, Beck Anxiety Inventory, and laboratory tests were also conducted. Results: The cortical thickness of the right rostral anterior cingulate gyrus (ACG) was significantly correlated with the Fried frailty index, age, and creatinine level. Multiple regression analysis indicated that the cortical thickness of the right rostral ACG was associated with frailty after controlling for age and creatinine level. Conclusion: Our results indicate that the cortical thickness of the rostral ACG may be associated with frailty in patients with ESRD on hemodialysis and that the rostral ACG may play a role in the frailty mechanism of this population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.